Innospec Financials

IOSP Stock  USD 99.17  1.08  1.10%   
Based on the measurements of operating efficiency obtained from Innospec's historical financial statements, Innospec is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At this time, Innospec's Property Plant And Equipment Gross is relatively stable compared to the past year. As of 03/18/2025, Total Current Assets is likely to grow to about 1 B, while Other Current Liabilities is likely to drop slightly above 111.6 M. Key indicators impacting Innospec's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.01830.0193
Notably Down
Slightly volatile
Return On Assets0.01950.0205
Notably Down
Slightly volatile
Return On Equity0.02790.0294
Notably Down
Slightly volatile
Debt Equity Ratio0.03520.0371
Notably Down
Slightly volatile
Operating Income100.7 M177.9 M
Way Down
Slightly volatile
Current Ratio1.492.5757
Way Down
Pretty Stable
The financial analysis of Innospec is a critical element in measuring its lifeblood. Investors should not minimize Innospec's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

58.06 Million

  
Understanding current and past Innospec Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Innospec's financial statements are interrelated, with each one affecting the others. For example, an increase in Innospec's assets may result in an increase in income on the income statement.

Innospec Stock Summary

Innospec competes with Minerals Technologies, Oil Dri, Quaker Chemical, Sensient Technologies, and H B. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people.
Specialization
Basic Materials, Specialty Chemicals
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS45768S1050
CUSIP45768S105 675727101
LocationColorado; U.S.A
Business Address8310 South Valley
SectorChemicals
IndustryMaterials
BenchmarkDow Jones Industrial
Websiteinnospec.com
Phone303 792 5554
CurrencyUSD - US Dollar

Innospec Key Financial Ratios

Innospec Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets1.4B1.6B1.6B1.7B1.7B1.1B
Other Current Liab136.4M171.7M194.3M191.7M190.6M111.6M
Net Debt(64.5M)(106.2M)(101.8M)(158.5M)(244.3M)(232.1M)
Retained Earnings758.6M822.9M924.2M1.0B1.0B1.1B
Accounts Payable98.7M148.7M165.3M163.6M163.8M91.8M
Cash105.3M141.8M147.1M203.7M289.2M303.7M
Net Receivables221.4M284.5M334.6M359.8M341.7M179.5M
Inventory220M277.6M373.1M300.1M301M175.6M
Other Current Assets19.5M24.2M17.8M22.1M24.7M25.9M
Total Liab452.5M537.9M563.3M557.8M518.6M472.5M
Total Current Assets566.2M728.1M872.6M885.7M956.6M1.0B
Short Term Debt11.8M12.5M27.8M13.6M13.9M20.3M
Intangible Assets75.3M57.5M45M57.3M65.4M122.2M
Other Liab165.4M171.1M178.2M126.1M145.0M101.8M
Other Assets130.9M175M171.2M61.1M70.3M86.2M
Good Will371.2M364.3M358.8M399.3M382.5M308.9M
Net Tangible Assets463.9M526.8M611.2M634.2M729.3M765.8M

Innospec Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory25.5M(62M)(98.5M)83M(11.8M)(11.2M)
Change In Cash29.6M36.5M5.3M56.6M85.5M89.8M
Free Cash Flow116.2M54.1M39.4M130.1M143.1M82.9M
Depreciation46M42.7M40.1M39.3M43.5M30.5M
Capital Expenditures29.7M39.1M42.3M62.1M41.4M24.6M
Net Income28.7M93.1M133M139.1M35.6M58.1M
End Period Cash Flow105.3M141.8M147.1M203.7M289.2M303.7M
Dividends Paid25.6M28.8M31.7M35.1M38.8M40.7M
Investments(29.7M)(36.2M)(42.1M)(71.1M)(62M)(58.9M)
Change Receivables(18.2M)74.4M(70.3M)(55.5M)(50.0M)(47.5M)
Net Borrowings(69.2M)(61.4M)(600K)(100K)(90K)(85.5K)
Change To Netincome5.4M25.1M5.5M1.2M1.4M1.4M

Innospec Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innospec's current stock value. Our valuation model uses many indicators to compare Innospec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innospec competition to find correlations between indicators driving Innospec's intrinsic value. More Info.
Innospec is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.40  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Innospec is roughly  2.53 . At this time, Innospec's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Innospec by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Innospec Systematic Risk

Innospec's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Innospec volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Innospec correlated with the market. If Beta is less than 0 Innospec generally moves in the opposite direction as compared to the market. If Innospec Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innospec is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innospec is generally in the same direction as the market. If Beta > 1 Innospec moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Innospec Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Innospec's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Innospec growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.98)

At this time, Innospec's Price Earnings To Growth Ratio is relatively stable compared to the past year.

Innospec March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Innospec help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innospec. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innospec based on widely used predictive technical indicators. In general, we focus on analyzing Innospec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innospec's daily price indicators and compare them against related drivers.

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.